Counting the cost of proton pump inhibitors.
نویسنده
چکیده
منابع مشابه
National use of proton pump inhibitors from 2007 to 2011.
National Use of Proton Pump Inhibitors From2007 to 2011 Proton pump inhibitors (PPIs) are a class of therapeutically equivalent medications when used at equivalent doses.1,2 Despite this, high-cost PPIs continue to be used when lowcost equivalents are available. We sought to estimate the national loss associated with the use of high-cost PPIs over their lower-cost alternatives. Furthermore, we ...
متن کاملClinical points of intravenous pantoprazole consumption in Cardiac ICU
Background: Proton pump inhibitors (PPIs) are the most common medicine for the treatment and prophylaxis of acid peptic conditions. The inappropriate use of the PPIs mainly intravenous form of Pantoprazole may lead to excessive cost and unexpected adverse effect. The purpose of our study was to evaluation the use of intravenous Pantoprazole in international heart center in north of Iran. Meth...
متن کاملCost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.
BACKGROUND The administration of proton pump inhibitors intravenously after endoscopic treatment of peptic ulcers significantly reduces the recurrence of bleeding. AIM To evaluate the incremental cost-effectiveness in Canada of intravenous proton pump inhibitor before endoscopic therapy to patients presenting with acute upper gastrointestinal bleeding, compared with endoscopic treatment alone...
متن کاملChronic Asthma and Gastro-Esophageal Reflux Disease: The Treatment Plans
Gastro-esophageal reflux disease (GERD) regularly occurs when stomach acid moves up from the stomach into the esophagus. GERD might be associated with chronic asthma symptoms such as coughing and breathlessness. According to several studies on children and adults, GERD is proven to have a close relationship with asthma. Medication treatment via proton-pump inhibitors (PPIs), such as Omeprazole,...
متن کاملOral Proton Pump Inhibitors
There is currently a lack of evidence to suggest superior clinical efficacy of one oral proton pump inhibitor over any other. Proton pump inhibitors display similar doseresponse relationships with similar potencies and efficacies at the equivalent dose. The decision to select one proton pump inhibitor over another is likely to be based on the agents’ licensed indication, patient tolerability an...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Gut
دوره 49 4 شماره
صفحات -
تاریخ انتشار 2001